Abnormal metabolic fate of nitric oxide in type I diabetes mellitus

Diabetologia

Volumn 45, Issue 11, 2002, Pages 1515-1522

  Milsom, A ^a   Jones, C ^a   Goodfellow, J ^a   Frenneaux, M ^a   Peters, J ^a   James, P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Bioavailability; Diabetes mellitus; Glycosylation; Haemoglobin; Metabolism; Nitric oxide; Nitrosyl haemoglobin

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN A1C; NITRATE; NITRIC OXIDE; NITRITE; PLASMA PROTEIN; PROTEIN; THIOL DERIVATIVE; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A, GLYCOSYLATED NITRIC OXIDE COMPLEX; HEMOGLOBIN A, GLYCOSYLATED-NITRIC OXIDE COMPLEX; TRIACYLGLYCEROL;

ADULT; ARTICLE; BINDING AFFINITY; BIOAVAILABILITY; BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM; HUMAN; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; OXYGENATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN GLYCOSYLATION; REGULATORY MECHANISM; SAMPLING; TISSUE PERFUSION; VASCULAR DISEASE; BLOOD; BLOOD SAMPLING; ELECTRON SPIN RESONANCE; GLUCOSE BLOOD LEVEL; GLYCOSYLATION; KINETICS; METHODOLOGY; ONSET AGE;

ADULT; AGE OF ONSET; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; BLOOD SPECIMEN COLLECTION; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; ELECTRON SPIN RESONANCE SPECTROSCOPY; GLYCOSYLATION; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS; HUMANS; KINETICS; NITRATES; NITRIC OXIDE; NITRITES; TRIGLYCERIDES;

EID: 0036435643     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0956-9     Document Type: Article

References (29)

1. Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA 241: 2035-2038
2. Keen H, Jarrett RJ (1979) The WHO multinational study of vascular disease in diabetes: 2. Macrovascular disease prevalence. Diabetes Care 2: 187-195
3. Ross R, Glomset JA (1973) Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 180: 1332-1339
4. Diamond JR, Karnovsky MJ (1988) Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int 33: 917-924
5. Porta M, La Selva M, Molinatti P, Molinatti GM (1987) Endothelial cell function in diabetic microangiopathy. Diabetologia 30: 601-609
6. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T (1989) Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1: 461-463
7. Gladwin MT, Ognibene FP, Pannell LK et al. (2000) Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. Proc Natl Acad Sci USA 97: 9943-9948
8. Gladwin MT, Shelhamer JH, Schechter AN et al. (2000) Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci USA 97: 11482-11487
9. Lewis TV, Dart AM, Chin-Dusting JP, Kingwell BA (1999) Exercise training increases basal nitric oxide production from the forearm in hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 19: 2782-2787
10. Scharfstein JS, Keaney JF Jr, Slivka A, Welch GN, Vita JA, Stamler JS, Loscalzo J (1994) In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest 94: 1432-1439
11. Stamler JS, Jia L, Eu JP et al. (1997) Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 276: 2034-2037
12. Pawloski JR, Hess DT, Stamler JS (2001) Export by red blood cells of nitric oxide bioactivity. Nature 409: 622-626
13. Gow AJ, Luchsinger BP, Pawloski JR, Singel DJ, Stamler JS (1999) The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci USA 96: 9027-9032
14. Kosaka H, Seiyama A (1997) Elevation of oxygen release by nitroglycerin without an increase in blood flow in the hepatic microcirculation. Nat Med 3: 456-459
15. Yonetani T, Tsuneshige A, Zhou Y, Chen X (1998) Electron paramagnetic resonance and oxygen binding studies of alpha-Nitrosyl hemoglobin. A novel oxygen carrier having no -assisted allosteric functions. J Biol Chem 273: 20323-20333
16. Keefer LK, Nims RW, Davies KM, Wink DA (1996) "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: Convenient nitric oxide dosage forms. Methods Enzymol 268: 281-293
17. Bain BJ, Bates I (2001) Basic haematological techniques. In: Mitchell-Lewis S, Bain BJ, Bates I (eds) Practical Haematology. 9th Edn, Churchill Livingston, London, pp 20-22
18. Gladwin MT, Schechter AN, Shelhamer JH et al. (1999) Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity. J Clin Invest 104: 937-945
19. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG (1993) A Fluorometric assay for the measurement of nitrite in biological samples. Biochemistry 214: 11-16
20. Stamler JS, Feelisch M (1996) Preparation and Detection of S-Nitrosothiols. In: Feelisch M, Stamler JS (eds) Methods in Nitric Oxide Research, John Wiley and Sons Ltd. Chichester, pp 527-527
21. Smith RJ, Koenig RJ, Binnerts A, Soeldner JS, Aoki TT (1982) Regulation of hemoglobin AIc formation in human erythrocytes in vitro. Effects of physiologic factors other than glucose. J Clin Invest 69: 1164-1168
22. De Rosa MC, Sanna MT, Messana I et al. (1998) Glycated human hemoglobin (HbA1c): functional characteristics and molecular modeling studies. Biophys Chem 72: 323-335
23. Padron J, Peiro C, Cercas E, Llergo JL, Sanchez-Ferrer CF (2000) Enhancement of S-nitrosylation in glycosylated hemoglobin. Biochem Biophys Res Commun 271: 217-221
24. UKPDS (1998) United Kingdom prospective diabetes study group. UK prospective study 33: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352: 837-853
25. DCCT (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329: 977-986
26. Rassaf T, Preik M, Kleinbongard P et al. (2002) Evidence for in vivo transport of bioactive nitric oxide in human plasma. J Clin Invest 109: 1241-1248
27. Cochrane SM, Byrne JC, Robinson GB (1997) The perm-selectivity of glomerular basement membrane can be compromised by glycation or by exposure to low levels of hypochlorite. Biochim Biophys Acta 1361: 217-228
28. Tarsio JF, Reger LA, Furcht LT (1987) Decreased interaction of fibronectin, type IV collagen, and heparin due to nonenzymatic glycation. Implications for diabetes mellitus. Biochemistry 26: 1014-1020
29. Graier WF, Posch K, Wascher TC, Kostner GM (1997) Role of superoxide anions in changes of endothelial vasoactive response during acute hyperglycemia. Horm Metab Res 29: 622-626